JPWO2024104354A5 - - Google Patents
Info
- Publication number
- JPWO2024104354A5 JPWO2024104354A5 JP2025525056A JP2025525056A JPWO2024104354A5 JP WO2024104354 A5 JPWO2024104354 A5 JP WO2024104354A5 JP 2025525056 A JP2025525056 A JP 2025525056A JP 2025525056 A JP2025525056 A JP 2025525056A JP WO2024104354 A5 JPWO2024104354 A5 JP WO2024104354A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- crystal form
- diffraction pattern
- ray powder
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211417721 | 2022-11-14 | ||
| CN202211417721.3 | 2022-11-14 | ||
| PCT/CN2023/131627 WO2024104354A1 (zh) | 2022-11-14 | 2023-11-14 | 一种取代的哌嗪衍生物的晶体及其制备方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025536416A JP2025536416A (ja) | 2025-11-05 |
| JP2025536416A5 JP2025536416A5 (https=) | 2026-04-10 |
| JPWO2024104354A5 true JPWO2024104354A5 (https=) | 2026-04-10 |
Family
ID=90997576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025525056A Pending JP2025536416A (ja) | 2022-11-14 | 2023-11-14 | 置換ピペラジン誘導体の結晶およびその調製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250270223A1 (https=) |
| EP (1) | EP4620958A1 (https=) |
| JP (1) | JP2025536416A (https=) |
| KR (1) | KR20250086779A (https=) |
| CN (1) | CN118027039A (https=) |
| AU (1) | AU2023381502A1 (https=) |
| MX (1) | MX2025005591A (https=) |
| TW (1) | TWI879228B (https=) |
| WO (1) | WO2024104354A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121729220A (zh) * | 2023-08-17 | 2026-03-24 | 康百达（四川）生物医药科技有限公司 | 一种哌嗪衍生物的药物制剂、其制备方法及其用途 |
| WO2025209574A1 (zh) * | 2024-04-03 | 2025-10-09 | 康百达（四川）生物医药科技有限公司 | 用于预防或治疗肿瘤的parp7抑制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3788040B1 (en) * | 2018-04-30 | 2023-04-12 | Ribon Therapeutics Inc. | Pyridazinones as parp7 inhibitors |
| US12371421B2 (en) * | 2019-04-29 | 2025-07-29 | Ribon Therapeutics, Inc. | Solid forms of a PARP7 inhibitor |
| CN112745312B (zh) * | 2019-10-30 | 2022-08-30 | 沈阳中化农药化工研发有限公司 | 哒嗪酮异恶唑甲醚类化合物及其应用 |
| WO2021087018A1 (en) * | 2019-10-30 | 2021-05-06 | Ribon Therapeutics, Inc. | Pyridazinones as parp7 inhibitors |
| WO2022111700A1 (zh) * | 2020-11-27 | 2022-06-02 | 成都百裕制药股份有限公司 | 哒嗪酮衍生物及其在医药上的应用 |
| WO2022156708A1 (en) * | 2021-01-20 | 2022-07-28 | Jacobio Pharmaceuticals Co., Ltd. | Parp7 enzyme inhibitor |
| CN117279917A (zh) * | 2021-05-21 | 2023-12-22 | 成都百裕制药股份有限公司 | 哌嗪衍生物及其在医药上的应用 |
-
2023
- 2023-11-14 EP EP23890787.7A patent/EP4620958A1/en active Pending
- 2023-11-14 WO PCT/CN2023/131627 patent/WO2024104354A1/zh not_active Ceased
- 2023-11-14 TW TW112143895A patent/TWI879228B/zh active
- 2023-11-14 CN CN202311526331.4A patent/CN118027039A/zh active Pending
- 2023-11-14 JP JP2025525056A patent/JP2025536416A/ja active Pending
- 2023-11-14 AU AU2023381502A patent/AU2023381502A1/en active Pending
- 2023-11-14 KR KR1020257016149A patent/KR20250086779A/ko active Pending
-
2025
- 2025-05-13 US US19/207,109 patent/US20250270223A1/en active Pending
- 2025-05-13 MX MX2025005591A patent/MX2025005591A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870001431B1 (ko) | 라니티딘 염산염의 제조방법 | |
| JP4138886B2 (ja) | ２−アミノ−４−（４−フルオルベンジルアミノ）−１−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法 | |
| JP2025176008A5 (https=) | ||
| EP4303212B1 (en) | Hydroxytyrosol nicotinamide eutectic crystal, and preparation method therefor and composition thereof | |
| JP7257328B2 (ja) | ベンゾフラン誘導体遊離塩基の結晶およびその製造方法 | |
| JP2024095561A5 (https=) | ||
| JPWO2022130304A5 (https=) | ||
| JP7433288B2 (ja) | イサブコナゾニウム硫酸塩を精製するための方法 | |
| KR20220016949A (ko) | Cdk9 억제제의 결정다형 및 이의 제조방법과 용도 | |
| CA2805959A1 (en) | Crystals of carboprost tromethamine and the preparation method as well as the uses thereof | |
| JPWO2024104354A5 (https=) | ||
| EA020545B1 (ru) | Соли карбоновой кислоты 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина | |
| WO2022078122A1 (zh) | 阿卡替尼的新晶型及其制备方法 | |
| JPWO2023194339A5 (https=) | ||
| WO2017020869A1 (zh) | 2-[(2r)-2-甲基-2-吡咯烷基]-1h-苯并咪唑-7-甲酰胺的晶型b及其制备方法和应用 | |
| EP3279182B1 (en) | Acetylsalicylic acid derivative crystal and preparation method and use thereof | |
| KR20230004723A (ko) | 프탈라지논 화합물의 결정형 | |
| CN110156860A (zh) | 一种高纯度奥贝胆酸的纯化方法 | |
| CA2549871A1 (en) | Novel polymorphs of atovaquone and process of preparation thereof | |
| US6277827B1 (en) | Single morphic forms of metalloproteinase inhibitors | |
| CN105503838B (zh) | 曲沙他滨的合成及其晶型 | |
| FI65773C (fi) | Foerfarande foer separering av d-2-(6-metoxi-2-naftyl)propionsyra | |
| CN109678872B (zh) | 双苄基异喹啉化合物及其制备方法和应用 | |
| JP2021512893A5 (https=) | ||
| JP2753910B2 (ja) | Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法 |